Literature DB >> 20013245

Neurobehavioral tests in rat models of degenerative brain diseases.

Yvonne K Urbach1, Felix J Bode, Huu Phuc Nguyen, Olaf Riess, Stephan von Hörsten.   

Abstract

Each translational approach in medical research forces the establishment of neurobehavioral screening systems, dedicated to fill the gap between postgenomic generation of state-of-the-art animal models (i.e. transgenic rats) on the one hand and their added value for really predictive experimental preclinical therapy on the other. Owing to these developments in the field, neuroscientists are frequently challenged by the task of detecting discrete behavioral differences in rats. Systematic, comprehensive phenotyping covers these needs and represents a central part of the process. In this chapter, we provide an overview on theoretical issues related to comprehensive neurobehavioral phenotyping of rats and propose specific classical procedures, protocols (similar to the SHIRPA approach in mice), as well as techniques for repeated, intraindividual phenotyping. Neurological testing of rats, motorfunctional screening using the accelerod approach, emotional screening using the social interaction test of anxiety, and testing of sensorimotoric gating functions by prepulse inhibition of the startle response are provided in more detail. This description is completed by an outlook on most recent developments in the field dealing with automated, intra-home-cage technologies, allowing continuous screening in rats in various behavioral and physiological dimensions on an ethological basis.

Entities:  

Mesh:

Year:  2010        PMID: 20013245     DOI: 10.1007/978-1-60327-389-3_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.

Authors:  Stefano Espinoza; Gabriele Lignani; Lucia Caffino; Silvia Maggi; Ilya Sukhanov; Damiana Leo; Liudmila Mus; Marco Emanuele; Giuseppe Ronzitti; Anja Harmeier; Lucian Medrihan; Tatyana D Sotnikova; Evelina Chieregatti; Marius C Hoener; Fabio Benfenati; Valter Tucci; Fabio Fumagalli; Raul R Gainetdinov
Journal:  Neuropsychopharmacology       Date:  2015-03-09       Impact factor: 7.853

2.  Paranoia as a deficit in non-social belief updating.

Authors:  Erin J Reed; Stefan Uddenberg; Praveen Suthaharan; Christoph D Mathys; Jane R Taylor; Stephanie Mary Groman; Philip R Corlett
Journal:  Elife       Date:  2020-05-26       Impact factor: 8.140

3.  Morinda citrifolia mitigates rotenone-induced striatal neuronal loss in male Sprague-Dawley rats by preventing mitochondrial pathway of intrinsic apoptosis.

Authors:  S Narasimhan Kishore Kumar; Jayakumar Deepthy; Uthamaraman Saraswathi; Mohan Thangarajeswari; Sathyamoorthy Yogesh Kanna; Pannerselvam Ezhil; Periandavan Kalaiselvi
Journal:  Redox Rep       Date:  2016-11-24       Impact factor: 4.412

4.  A mutation in Myo15 leads to Usher-like symptoms in LEW/Ztm-ci2 rats.

Authors:  Nadine Held; Bart M G Smits; Roland Gockeln; Stephanie Schubert; Heike Nave; Emily Northrup; Edwin Cuppen; Hans J Hedrich; Dirk Wedekind
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

5.  Altered diffusion tensor imaging measurements in aged transgenic Huntington disease rats.

Authors:  Bjørnar T Antonsen; Yi Jiang; Jelle Veraart; Hong Qu; Huu Phuc Nguyen; Jan Sijbers; Stephan von Hörsten; G Allan Johnson; Trygve B Leergaard
Journal:  Brain Struct Funct       Date:  2012-05-23       Impact factor: 3.270

6.  Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats.

Authors:  Christina L Nemeth; Erica R Glasper; Constance S Harrell; Sanjana A Malviya; Jeffrey S Otis; Gretchen N Neigh
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

7.  Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51trunc Model of Huntington Disease.

Authors:  Anne-Christine Plank; Fabio Canneva; Kerstin A Raber; Yvonne K Urbach; Julia Dobner; Maja Puchades; Jan G Bjaalie; Clarissa Gillmann; Tobias Bäuerle; Olaf Riess; Hoa H P Nguyen; Stephan von Hörsten
Journal:  Front Neurosci       Date:  2018-01-25       Impact factor: 4.677

Review 8.  Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization-A Joint Initiative.

Authors:  Philippe Robert; Thomas Frenzel; Cécile Factor; Gregor Jost; Marlène Rasschaert; Gunnar Schuetz; Nathalie Fretellier; Janina Boyken; Jean-Marc Idée; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2018-09       Impact factor: 6.016

9.  Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition.

Authors:  Florian A Siebzehnrübl; Kerstin A Raber; Yvonne K Urbach; Anja Schulze-Krebs; Fabio Canneva; Sandra Moceri; Johanna Habermeyer; Dalila Achoui; Bhavana Gupta; Dennis A Steindler; Michael Stephan; Huu Phuc Nguyen; Michael Bonin; Olaf Riess; Andreas Bauer; Ludwig Aigner; Sebastien Couillard-Despres; Martin Arce Paucar; Per Svenningsson; Alexander Osmand; Alexander Andreew; Claus Zabel; Andreas Weiss; Rainer Kuhn; Saliha Moussaoui; Ines Blockx; Annemie Van der Linden; Rachel Y Cheong; Laurent Roybon; Åsa Petersén; Stephan von Hörsten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-27       Impact factor: 11.205

10.  Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease.

Authors:  Alexis Faure; Mouna Es-Seddiqi; Bruce L Brown; Hoa P Nguyen; Olaf Riess; Stephan von Hörsten; Pascale Le Blanc; Nathalie Desvignes; Bruno Bozon; Nicole El Massioui; Valérie Doyère
Journal:  Front Behav Neurosci       Date:  2013-09-26       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.